Cargando…
Corrigendum: rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891283/ https://www.ncbi.nlm.nih.gov/pubmed/36741359 http://dx.doi.org/10.3389/fimmu.2022.1104646 |
| _version_ | 1784881109687861248 |
|---|---|
| author | Shen, Weiran Liu, Shengjiang Ou, Li |
| author_facet | Shen, Weiran Liu, Shengjiang Ou, Li |
| author_sort | Shen, Weiran |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9891283 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98912832023-02-02 Corrigendum: rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis Shen, Weiran Liu, Shengjiang Ou, Li Front Immunol Immunology Frontiers Media S.A. 2023-01-18 /pmc/articles/PMC9891283/ /pubmed/36741359 http://dx.doi.org/10.3389/fimmu.2022.1104646 Text en Copyright © 2023 Shen, Liu and Ou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Shen, Weiran Liu, Shengjiang Ou, Li Corrigendum: rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis |
| title | Corrigendum: rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis |
| title_full | Corrigendum: rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis |
| title_fullStr | Corrigendum: rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis |
| title_full_unstemmed | Corrigendum: rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis |
| title_short | Corrigendum: rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis |
| title_sort | corrigendum: raav immunogenicity, toxicity, and durability in 255 clinical trials: a meta-analysis |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891283/ https://www.ncbi.nlm.nih.gov/pubmed/36741359 http://dx.doi.org/10.3389/fimmu.2022.1104646 |
| work_keys_str_mv | AT shenweiran corrigendumraavimmunogenicitytoxicityanddurabilityin255clinicaltrialsametaanalysis AT liushengjiang corrigendumraavimmunogenicitytoxicityanddurabilityin255clinicaltrialsametaanalysis AT ouli corrigendumraavimmunogenicitytoxicityanddurabilityin255clinicaltrialsametaanalysis |